Having received marketing authorization from the US Food and Drug Administration, the First To Know Syphilis Test from Arkansas-based NOWDiagnostics becomes the first at-home test to detect the sexually transmitted disease without a prescription.
NOWDiagnostics Wins De Novo For First OTC Syphilis Test
The US FDA has granted marketing authorization to NOWDiagnostics for the first at-home over-the-counter test to detect syphilis, which the government says is on the rise.
More from Regulation
More from Policy & Regulation
• By
Cybersecurity, sustainability and regulatory intelligence all need factoring into risk management today as AI and data availability change the goalposts. Eight experts tell Medtech Insight how compliance efforts must adapt.
• By
About 3,500 full-time FDA employees are expected to be laid off as part of a restructuring of the Health and Human Services Department. Experts questioned whether the cuts could be implemented without harming FDA’s core mission.
• By
The IVD industry’s new 10-point plan for healthcare change shows that medtechs will keep calling the German government to account. Tariffs, sector resilience, digital functionality are among the pressing issues industry wants answers to.